Syndax's revumenib shows 26% complete remission rate in AML study

6 months ago 16
Read Entire Article
  1. Homepage
  2. Finance
  3. Syndax's revumenib shows 26% complete remission rate in AML study

Related

China says it hopes firms seek lawful, balanced solutions over TikTok deal

China says it hopes firms seek lawful, balanced solutions ov...

1 hour ago 2
China accuses US of distorting its defence policy in relation to India ties

China accuses US of distorting its defence policy in relatio...

1 hour ago 2
Japan stocks higher at close of trade; Nikkei 225 up 0.08%

Japan stocks higher at close of trade; Nikkei 225 up 0.08%

2 hours ago 2

Trending

1. lol
2. sydney kings
3. apple news
4. marvel
5. nytimes.com
6. taylor swift news
7. prisoners
8. is sheetz open on christmas
9. retire
10. economy

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

11 months ago 645
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

9 months ago 512
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

9 months ago 377
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

9 months ago 334
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

11 months ago 329
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved